{"company":{"id":2676315,"name":"ImpriMed, Inc.","domain":"imprimedicine.com","url":"https://alion.io/company/imprimedicine"},"section":"news","answer":"ImpriMed, Inc.: 18 headlines on record, 5 headlines in the last 90 days. Its story counts 4 milestones.","figures":[{"label":"Headlines","value":"18"},{"label":"In 90 days","value":"5"},{"label":"Milestones","value":"4"}],"blocks":[{"key":"news","title":"Headlines","source":"the outlets named on each headline, each story once","rows":16},{"key":"story","title":"Milestones","source":"Each milestone is dated by its source: registers, filings, the press","rows":4}],"news":[{"date":"2026-09-29","kind":"News","title":"From Dogs to Humans: AI-Powered Drug Response Prediction Technology Demonstrates Improved Clinical Outcomes in Oncology Pharmacy Times","source":"Pharmacy Times","url":"https://pharmacytimes.com/view/from-dogs-to-humans-ai-powered-drug-response-prediction-technology-demonstrates-improved-clinical-outcomes-in-oncology"},{"date":"2026-09-29","kind":"News","title":"Comparative Oncology: Advances in Cancer Care from Pets to Humans Pharmacy Times","source":"Pharmacy Times","url":"https://pharmacytimes.com/view/comparative-oncology-advances-in-cancer-care-from-pets-to-humans"},{"date":"2026-09-29","kind":"News","title":"New AI service offers personalized drug response predictions for canine patients with cancer","source":"dvm360","url":"https://dvm360.com/view/new-ai-service-offers-personalized-drug-response-predictions-for-canine-patients-with-cancer"},{"date":"2026-09-29","kind":"News","title":"Flow cytometry and clonality evaluation are effective for characterizing feline lymphoma","source":"dvm360","url":"https://dvm360.com/view/flow-cytometry-and-clonality-evaluation-are-effective-for-characterizing-feline-lymphoma"},{"date":"2026-09-17","kind":"News","title":"NAVER D2SF Invests in AI-Driven Precision Medicine Company ImpriMed","source":"tmcnet.com","url":"https://tmcnet.com/usubmit/2026/09/18/10448330.htm"},{"date":"2026-07-01","kind":"Press release","title":"ImpriMed CEO Dr. Sungwon Lim Invited to National Cancer Institute Panel on Commercializing Functional Precision Medicine","source":"businesswire","url":"https://businesswire.com/news/home/20260701788991/en/ImpriMed-CEO-Dr.-Sungwon-Lim-Invited-to-National-Cancer-Institute-Panel-on-Commercializing-Functional-Precision-Medicine"},{"date":"2024-09-22","kind":"Press release","title":"ImpriMed Unveils Cancer Treatment Prediction Technology at EHA-SfPM Meeting, Expands AI-Driven Precision Medicine Services from Pets to Humans","source":"businesswire.com","url":"https://businesswire.com/news/home/20240923577061/en/ImpriMed-Unveils-Cancer-Treatment-Prediction-Technology-at-EHA-SfPM-Meeting-Expands-AI-Driven-Precision-Medicine-Services-from-Pets-to-Humans/"},{"date":"2024-06-12","kind":"News","title":"ImpriMed: Providing Personalized Medicine For Pets With Blood Cancer Diseases In A $1+ Billion Market","source":"Pulse 2.0","url":"https://pulse2.com/imprimed-sungwon-lim-profile/"},{"date":"2024-01-29","kind":"News","title":"How AI Can Help Treat (and Cure) Your Dog's Cancer","source":"The Daily Beast","url":"https://thedailybeast.com/how-ai-from-imprimed-can-help-treat-and-cure-your-dogs-cancer/"},{"date":"2023-12-21","kind":"News","title":"ImpriMed: Precision Medicine Company Secures $23 Million To Improve Cancer Treatment","source":"Pulse 2.0","url":"https://pulse2.com/imprimed-23-million-funding/"},{"date":"2023-12-19","kind":"News","title":"Dog cancer treatment ImpriMed aims to expand its AI technology into human oncology","source":"TechCrunch","url":"https://techcrunch.com/2023/12/19/dog-cancer-treatment-imprimed-aims-to-expand-its-ai-technology-into-human-oncology/"},{"date":"2023-12-18","kind":"Press release","title":"ImpriMed Raises $23 Million Series A Round to Expand its Revolutionary AI-Powered Cancer Treatment Technology","source":"businesswire.com","url":"https://businesswire.com/news/home/20231219536657/en/ImpriMed-Raises-23-Million-Series-A-Round-to-Expand-its-Revolutionary-AI-Powered-Cancer-Treatment-Technology/"},{"date":"2021-05-24","kind":"News","title":"ImpriMed Launches Chemo Response Prediction and Immunophenotyping Services for Canine Lymphoma","source":"YahooFinance","url":"https://finance.yahoo.com/news/imprimed-launches-chemo-response-prediction-120000758.html"},{"kind":"News","title":"How ImpriMed Turned Nine Years in Veterinary Oncology Into a Human Blood Cancer Business","source":"synbiobeta.com","url":"https://synbiobeta.com/read/how-imprimed-turned-nine-years-in-veterinary-oncology-into-a-human-blood-cancer-business"},{"kind":"News","title":"One moment, please...","source":"veterinary-practice.com","url":"https://veterinary-practice.com/2024/cell-sizing-method-for-feline-lymphoma-characterisation"},{"kind":"News","title":"Client Challenge","source":"link.springer.com","url":"https://link.springer.com/article/10.1007/s12257-026-00289-z"}],"story":[{"title":"Launched ImpriMed Unveils Cancer Treatment Prediction Technology at EHA-SfPM Meeting, Expands AI-Driven Precision Medicine Services from Pets to Humans · businesswire.com","url":"https://businesswire.com/news/home/20240923577061/en/ImpriMed-Unveils-Cancer-Treatment-Prediction-Technology-at-EHA-SfPM-Meeting-Expands-AI-Driven-Precision-Medicine-Services-from-Pets-to-Humans/"},{"title":"Raised a round Series A $23M","url":"https://businesswire.com/news/home/20231219536657/en/ImpriMed-Raises-23-Million-Series-A-Round-to-Expand-its-Revolutionary-AI-Powered-Cancer-Treatment-Technology/"},{"title":"Launched ImpriMed Launches Chemo Response Prediction and Immunophenotyping Services for Canine Lymphoma · YahooFinance","url":"https://finance.yahoo.com/news/imprimed-launches-chemo-response-prediction-120000758.html"},{"title":"Founded"}],"as_of":"2026-11-17","cite":"ImpriMed, Inc., News. Alion, Nov 17, 2026. https://alion.io/company/imprimedicine/news","html_url":"https://alion.io/company/imprimedicine/news","json_url":"https://alion.io/company/imprimedicine/news.json","license":"CC BY-SA 4.0","meta":{"source":"Alion","generated_at":"2026-11-17T06:13:14Z"}}